NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

血管內皮層生長因子(VEGF)抑制劑的全球市場(2020年∼2030年):Covid-19的成長與變化

Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2020-30: COVID-19 Growth and Change

出版商 The Business Research Company 商品編碼 977387
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 2-10個工作天內
價格
血管內皮層生長因子(VEGF)抑制劑的全球市場(2020年∼2030年):Covid-19的成長與變化 Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2020-30: COVID-19 Growth and Change
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球血管內皮層生長因子(VEGF)抑制劑市場的相關調查,市場規模與預測,趨勢,策略,佔有率,成長及阻礙因素,各藥物類型、給藥途徑、用途、地區/國家的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模與成長

  • 全球市場(2015-2019)
    • 市場成長要素
    • 阻礙市場要素
  • 全球市場預測(2019-2023F,2025F,2030F)

第4章 市場區隔

  • 全球市場及預測:各藥物類型(2015-2019,2023F,2025F,2030F)
  • Avastin
  • Tecentriq
  • Cometriq
  • Eylea
  • 其他
  • 全球市場及預測:各給藥途徑(2015-2019,2023F,2025F,2030F)
  • 口服
  • 靜脈內
  • 全球市場及預測:各用途(2015-2019,2023F,2025F,2030F)
  • 腫瘤學
  • 眼科
  • 其他

第5章 各地區/國家分析

  • 全球市場及預測:各地區(2015-2019,2023F,2025F,2030F)
  • 全球市場及預測:各國(2015-2019,2023F,2025F,2030F)

第6章 亞太地區

第7章 中國

第8章 印度

第9章 日本

第10章 澳洲

第11章 印尼

第12章 韓國

第13章 西歐

第14章 英國

第15章 德國

第16章 法國

第17章 東歐

第18章 俄羅斯

第19章 北美

第20章 美國

第21章 南美

第22章 巴西

第23章 中東

第24章 非洲

第25章 競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Pfizer
    • Amgen
    • Roche
    • Xbrane Biopharma AB
    • Genentech Inc.

第26章 主要合併和收購

第27章 市場趨勢與策略

第28章 市場未來展望和潛力分析

第29章 附錄

目錄

“Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2020-30: COVID-19 Growth and Change” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global vascular endothelial growth factor (vegf) inhibitor market.

This report focuses on vascular endothelial growth factor (vegf) inhibitor market which is experiencing strong growth. The report gives a guide to the vascular endothelial growth factor (vegf) inhibitor market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the vascular endothelial growth factor (vegf) inhibitor? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Vascular Endothelial Growth Factor (VEGF) Inhibitor market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider vascular endothelial growth factor (vegf) inhibitor market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The vascular endothelial growth factor (vegf) inhibitor market section of the report gives context. It compares the vascular endothelial growth factor (vegf) inhibitor market with other segments of the vascular endothelial growth factor (vegf) inhibitor market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, vascular endothelial growth factor (vegf) inhibitor indicators comparison.

Scope

Markets Covered:

  • 1) By Drugs Type: Avastin; Tecentriq; Cometriq; Eylea; Others
  • 2) By route of administration: Oral; Intravenous
  • 3) By Application: Oncology; Ophthalmology; Others
  • Companies Mentioned: Pfizer; Amgen; Roche; Xbrane-Stada Arzneimittel; Genentech Inc. (Roche)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Characteristics

3. Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Size And Growth

  • 3.1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Segmentation

  • 4.1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Avastin
  • Tecentriq
  • Cometriq
  • Eylea
  • Others
  • 4.2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By route of administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Intravenous
  • 4.3. Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oncology
  • Ophthalmology
  • Others

5. Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Regional And Country Analysis

  • 5.1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 6.1. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 6.2. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 7.1. China Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 7.2. China Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 8.1. India Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 8.2. India Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 9.1. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 9.2. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 10.1. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 11.1. Indonesia Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 12.1. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 13.1. Western Europe Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 13.2. Western Europe Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 14.1. UK Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 14.2. UK Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 15.1. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 16.4. France Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 17.1. Eastern Europe Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 17.2. Eastern Europe Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 18.1. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 19.1. North America Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 19.2. North America Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 20.1. USA Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 20.2. USA Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 21.1. South America Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 21.2. South America Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 22.1. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 23.1. Middle East Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 23.2. Middle East Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

  • 24.1. Africa Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Overview
  • 24.2. Africa Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Drugs Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Vascular Endothelial Growth Factor (VEGF) Inhibitor Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Competitive Landscape And Company Profiles

  • 25.1. Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Competitive Landscape
  • 25.2. Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Company Profiles
    • 25.2.1. Pfizer
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Amgen
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Roche
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Xbrane Biopharma AB
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Genentech Inc.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

27. Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Trends And Strategies

28. Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer